SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Trading Statement

11 Apr 2019 07:00

RNS Number : 8302V
Oxford Instruments PLC
11 April 2019
Β 

Β 

Β 

Oxford Instruments plc

Trading Update 11 April 2019

Β 

Oxford Instruments plc, a leading provider of high technology products and services to industrial companies and scientific research communities, is today issuing a trading update.

Β 

As predicted, trading in the second half of the year was supported by a strong order book and our normal second half seasonal bias. We expect adjusted operating profit for the full year to be around the higher end of expectations1, despite a small adverse currency effect.

Β 

A good cash conversion during the year has resulted in the Group achieving a positive net cash position as at 31 March 2019.

Β 

Oxford Instruments' results for the year ended 31 March 2019 will be released on 11 June 2019.

Β 

Β 

Β 

1 Oxford Instruments compiled analyst forecast range for adjusted operating profit (year to 31 March 2019): Β£46.0m to Β£49.2m

Β 

Β 

Enquiries:

Β 

Oxford Instruments plc Tel: 01865 393200

Ian Barkshire, Chief Executive

Gavin Hill, Group Finance Director

Β 

MHP Communications Tel: 020 3128 8100

Rachel Hirst/Luke Briggs

Β 

Β 

Β 

- Ends -

Issued for and on behalf of Oxford Instruments plc

Notes to EditorsΒ Β 

Β 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion.Β 

Β 

The first technology business to be spun out fromΒ OxfordΒ University, Oxford Instruments is now a global company and is listed on the London Stock Exchange (OXIG). Its objective is toΒ be the leading provider of new generation tools and systems for the research and industrial sectors with a focus on nanotechnology. Its key market sectors include nano-fabrication and nano-materials. The company's strategy is to expand the business into the life sciences arena, where nanotechnology and biotechnology intersect.

Β 

This involves the combination of core technologies in areas such as low temperature and high magnetic field environments; NuclearΒ Magnetic Resonance; X-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; advanced growth, deposition and etching.

Β 

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. ItsΒ products, expertise, and ideas address global issues such as energy, environment, security and health.Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTDBLFFKZFEBBE
Date   Source Headline
4th Feb 20267:00 amPRNTransaction in Own Shares
3rd Feb 20267:00 amPRNTransaction in Own Shares
2nd Feb 20262:53 pmPRNTotal Voting Rights
2nd Feb 20267:59 amPRNTransaction in Own Shares
30th Jan 20267:00 amPRNTransaction in Own Shares
29th Jan 20267:00 amPRNTransaction in Own Shares
28th Jan 20267:00 amPRNTransaction in Own Shares
27th Jan 20267:00 amPRNTransaction in Own Shares
26th Jan 20267:00 amPRNTransaction in Own Shares
23rd Jan 20264:26 pmPRNHolding(s) in Company
22nd Jan 20267:00 amPRNTransaction in Own Shares
21st Jan 20267:00 amPRNTransaction in Own Shares
20th Jan 20267:00 amPRNTransaction in Own Shares
19th Jan 20269:39 amPRNHolding(s) in Company
15th Jan 20267:00 amRNSTrading Update
15th Jan 20267:00 amPRNTransaction in Own Shares
14th Jan 20262:15 pmPRNHolding(s) in Company
13th Jan 20264:15 pmPRNHolding(s) in Company
13th Jan 20267:00 amPRNTransaction in Own Shares
12th Jan 20267:00 amPRNTransaction in Own Shares
9th Jan 20267:00 amPRNTransaction in Own Shares
8th Jan 20267:00 amPRNTransaction in Own Shares
7th Jan 20267:00 amPRNTransaction in Own Shares
6th Jan 20267:00 amPRNTransaction in Own Shares
2nd Jan 202612:44 pmPRNBlock listing Interim Review
2nd Jan 202612:26 pmPRNTotal Voting Rights
23rd Dec 20253:32 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:32 pmPRNDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amPRNTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amPRNTransaction in Own Shares
18th Dec 20257:00 amPRNTransaction in Own Shares
17th Dec 20253:16 pmPRNHolding(s) in Company
17th Dec 20257:00 amPRNTransaction in Own Shares
16th Dec 20257:00 amPRNTransaction in Own Shares
15th Dec 20257:00 amPRNTransaction in Own Shares
12th Dec 20257:00 amPRNTransaction in Own Shares
11th Dec 20257:00 amPRNTransaction in Own Shares
10th Dec 20257:00 amPRNTransaction in Own Shares
9th Dec 20257:00 amPRNTransaction in Own Shares
8th Dec 20252:37 pmPRNHolding(s) in Company
3rd Dec 20257:00 amPRNTransaction in Own Shares
2nd Dec 20257:00 amPRNTransaction in Own Shares
1st Dec 202510:37 amPRNTotal Voting Rights
1st Dec 20257:00 amPRNTransaction in Own Shares
28th Nov 20257:00 amPRNTransaction in Own Shares
27th Nov 20257:00 amPRNTransaction in Own Shares
26th Nov 20257:00 amPRNTransaction in Own Shares
25th Nov 20257:00 amPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.